FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Cinryze, 1st Therapy for Rare Genetic Disease, OKd

[ Price : $8.95]

CBER approves a BLA for Lev Pharmaceuticals Cinryze, the first U.S. treatment for people with rare hereditary angioedema, a potent...

FDA Approves New Seroquel Indications

[ Price : $8.95]

FDA approves two new bipolar disorder indications for AstraZenecas Seroquel XR.

Nexium Web Site Has Most Visitors

[ Price : $8.95]

comScore says AstraZenecas Nexium Web site drew the highest number of unique visitors in the second quarter of 2008.

FDA to Miss User Fee Date on Diabetes Drug

[ Price : $8.95]

FDA tells Takeda Pharmaceutical that it will miss the 10/27 drug user fee review deadline for its NDA on SYR-322 (alogliptin), ind...

FDA Approves New Kogenate Indication

[ Price : $8.95]

FDA approves a new indication for Bayers Kogenate.

Panel to Discuss Novartis Malaria Treatment

[ Price : $8.95]

Federal Register Notice: FDAs Anti-Infective Drugs Advisory Committee will meet 12/3 to discuss Novartis NDA for treating malaria....

Panel to Discuss Acuspheres Ultrasound Agent

[ Price : $8.95]

Federal Register Notice: FDAs Cardiovascular and Renal Drugs Advisory Committee will meet 12/10 to discuss Acusphere Inc.s NDA for...

Panel to Discuss Dermal Filler/Cosmetic Devices

[ Price : $8.95]

Federal Register Notice: FDAs General and Plastic Surgery Devices Panel will meet 11/18-19 to discuss dermal fillers and clinical ...

Justice Withdraws Motion on Ranbaxy Privileged Documents

[ Price : $8.95]

Satisfied with Ranbaxys current cooperation, the U.S. Justice Department withdraws a motion to compel the troubled Indian generic ...

FDA Says Imaging Agent Shortage Continues

[ Price : $8.95]

FDA says that Mallinckrodt continues to experience a short supply of imaging agent Ultra-TechneKow DTE.